IL55660A - Pharmaceutical compositions containing amoxycillin trihydrate and potassium clavulanate - Google Patents

Pharmaceutical compositions containing amoxycillin trihydrate and potassium clavulanate

Info

Publication number
IL55660A
IL55660A IL55660A IL5566078A IL55660A IL 55660 A IL55660 A IL 55660A IL 55660 A IL55660 A IL 55660A IL 5566078 A IL5566078 A IL 5566078A IL 55660 A IL55660 A IL 55660A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
potassium clavulanate
amoxycillin trihydrate
containing amoxycillin
Prior art date
Application number
IL55660A
Other languages
English (en)
Other versions
IL55660A0 (en
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10423254&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL55660(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IL55660A0 publication Critical patent/IL55660A0/xx
Publication of IL55660A publication Critical patent/IL55660A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL55660A 1977-10-11 1978-09-28 Pharmaceutical compositions containing amoxycillin trihydrate and potassium clavulanate IL55660A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4219177 1977-10-11

Publications (2)

Publication Number Publication Date
IL55660A0 IL55660A0 (en) 1978-12-17
IL55660A true IL55660A (en) 1981-09-13

Family

ID=10423254

Family Applications (1)

Application Number Title Priority Date Filing Date
IL55660A IL55660A (en) 1977-10-11 1978-09-28 Pharmaceutical compositions containing amoxycillin trihydrate and potassium clavulanate

Country Status (24)

Country Link
US (2) US4441609A (ja)
JP (1) JPS5476831A (ja)
AU (1) AU525089B2 (ja)
BE (1) BE870988A (ja)
CA (1) CA1105385A (ja)
CH (1) CH642258A5 (ja)
DE (1) DE2843318A1 (ja)
FR (1) FR2405711A1 (ja)
GB (1) GB2005538B (ja)
HK (1) HK73785A (ja)
IE (1) IE47450B1 (ja)
IL (1) IL55660A (ja)
IT (1) IT1109273B (ja)
JO (1) JO984B1 (ja)
KE (1) KE3525A (ja)
MT (1) MTP836B (ja)
MY (1) MY8500996A (ja)
NL (1) NL190631B (ja)
NZ (1) NZ188497A (ja)
PL (1) PL210174A1 (ja)
PT (1) PT68600A (ja)
SE (2) SE435899B (ja)
SG (1) SG34985G (ja)
ZA (1) ZA785682B (ja)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
ES444948A1 (es) * 1975-02-07 1977-08-16 Glaxo Lab Ltd Un procedimiento para la separacion de impurezas contaminan-tes del acido clavulanico.
DE2964817D1 (en) * 1978-09-06 1983-03-24 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
GR70283B (ja) * 1979-10-02 1982-09-03 Beecham Group Ltd
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US4406887A (en) * 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
DE3266580D1 (en) * 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
US5743398A (en) * 1984-05-22 1998-04-28 Southpac Trust International, Inc. Floral wrapper utilizing a breathable packaging material
FR2593152B1 (fr) * 1986-01-22 1988-12-23 Adir Conditionnement etanche sous forme de plaquettes alveolaire permettant des echanges gazeux entre les alveoles.
EP0273209B1 (en) * 1986-12-30 1992-01-15 American Cyanamid Company Composition of matter containing polycarbophil
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition
US5643902A (en) * 1990-04-26 1997-07-01 Pfizer Inc. Veterinary treatment
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9411626D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Package
DE69523757T2 (de) * 1994-08-05 2002-08-01 West Pharm Serv Cornall Ltd Behälter für feuchtickeitsempfindliche stoffe und entsprechendes verfahren zum trocknen und zur reduktion
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
KR100495585B1 (ko) * 1995-09-07 2005-09-09 스미스클라인비이참피이엘시이 제약 제제
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
ITMI952354A1 (it) * 1995-11-16 1997-05-16 Smithkline Beecham Spa Composizione farmaceutica
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
AT407214B (de) * 1996-03-13 2001-01-25 Biochemie Gmbh Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
US6112888A (en) * 1996-06-28 2000-09-05 W. R. Grace & Co.-Conn. Non-reclosable packages containing desiccant matrix
US6180708B1 (en) 1996-06-28 2001-01-30 W. R. Grace & Co.-Conn. Thermoplastic adsorbent compositions containing wax and insulating glass units containing such compositions
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
ES2201468T3 (es) * 1997-02-14 2004-03-16 Laboratoire Glaxosmithkline S.A.S. Preparacion farmaceutica que comprende amoxicilina y clavulanato.
AU1232500A (en) * 1998-10-30 2000-05-22 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
ATE319447T1 (de) * 1999-08-16 2006-03-15 Revaax Pharmaceuticals Llc Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
SI20411A (sl) * 1999-12-22 2001-06-30 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Vodotopni praški za peroralno raztopino in njihova uporaba
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
AT412213B (de) * 2000-05-30 2004-11-25 Sandoz Ag Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AU2001292185A1 (en) 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
WO2004016262A1 (ja) * 2002-08-12 2004-02-26 Kyowa Hakko Kogyo Co., Ltd. アミノ酸含有チュアブル錠
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
MY147756A (en) * 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
EP2175999B1 (en) 2007-06-21 2017-01-04 Gen-Probe Incorporated Receptacles for use in performing processes
AU2008317315A1 (en) * 2007-10-26 2009-04-30 Rexahn Pharmaceuticals, Inc. Pharmaceutical formulation of clavulanic acid
US20100255099A1 (en) * 2007-10-26 2010-10-07 Rexahn Pharmaceuticals, Inc. Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) * 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128135A (en) * 1962-05-29 1964-04-07 Anaconda Wire & Cable Co Moisture-free package
US3567085A (en) * 1968-12-02 1971-03-02 James G Flores Neck-supported pill container
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions

Also Published As

Publication number Publication date
SE435899B (sv) 1984-10-29
MY8500996A (en) 1985-12-31
AU525089B2 (en) 1982-10-21
US4301149A (en) 1981-11-17
BE870988A (fr) 1979-04-03
HK73785A (en) 1985-10-04
IL55660A0 (en) 1978-12-17
FR2405711B1 (ja) 1982-10-29
PT68600A (en) 1978-10-01
IT1109273B (it) 1985-12-16
SE7810591L (sv) 1979-04-12
CA1105385A (en) 1981-07-21
JPS6341886B2 (ja) 1988-08-19
SE451668B (sv) 1987-10-26
CH642258A5 (de) 1984-04-13
IT7851415A0 (it) 1978-10-09
PL210174A1 (ja) 1980-08-11
NZ188497A (en) 1981-05-01
JPS5476831A (en) 1979-06-19
NL7810176A (nl) 1979-04-17
US4441609A (en) 1984-04-10
GB2005538A (en) 1979-04-25
AU4050678A (en) 1980-04-17
MTP836B (en) 1979-05-11
SE8107592L (sv) 1981-12-17
SG34985G (en) 1985-11-15
IE47450B1 (en) 1984-03-21
NL190631B (nl) 1994-01-03
GB2005538B (en) 1982-05-26
IE782019L (en) 1979-04-11
KE3525A (en) 1985-05-31
FR2405711A1 (fr) 1979-05-11
DE2843318A1 (de) 1979-04-12
ZA785682B (en) 1979-09-26
JO984B1 (en) 1979-12-01

Similar Documents

Publication Publication Date Title
IL55660A (en) Pharmaceutical compositions containing amoxycillin trihydrate and potassium clavulanate
NZ186842A (en) Cephem derivatives and pharmaceutical compositions containing them
NZ198241A (en) Tablet containing amoxycillin and potassium clavulanate
NZ188872A (en) 9-(-heteroarylamino-alkylamino)-erthromycins and pharmaceutical compositions
NZ186965A (en) Guanidino derivatives and pharmaceutical compositions
PH14216A (en) Polyene compounds and pharmaceutical compositions
NZ188170A (en) Propenylamines and pharmaceutical compositions
NZ187235A (en) Aminoalkylbenzene derivatives and pharmaceutical compositions
NZ187794A (en) 1-acyl-2-cynanoaziridines and immunestimulating pharmaceutical compositions
DE2861282D1 (en) Antibiotics and pharmaceutical compositions containing them
JPS5455566A (en) Organic compound and pharmaceutical composition
DE2862107D1 (en) Glucosamine-peptide derivatives and their pharmaceutical compositions
IL51339A0 (en) New beta-lactam containing compounds their preparation and pharmaceutical compositions containing them
GB2010256B (en) Cephalosporin compounds formulations containing them their preparation and use
NZ188531A (en) W-mercapto-propionamides and pharmaceutical compositions
NZ188772A (en) Pyrazinobenzoxazepine derivatives and pharmaceutical compositions
NZ188625A (en) Furan derivatives and pharmaceutical compositions containing them
NZ191981A (en) Pharmaceutical composition containing amoxycillin and polyvinylpyrrolidone
NZ188798A (en) 2-iminoimidazolidine derivatives and pharmaceutical compositions
NZ186689A (en) Substituted bis-benzimidazolyl compounds and pharmaceutical compositions
NZ187571A (en) N-glucofuranosid-6-yl-n-nitroso-urea derivatives and pharmaceutical compositions
NZ187085A (en) 3-pyridazione derivatives and pharmaceutical compositions
JPS5470255A (en) Nnbenzylanthracycline and pharmaceutical composition
IL55206A (en) Pharmaceutical compositions comprising clavulanic acid and certain beta-lactam antibiotics
NZ187285A (en) Azacyclic derivatives of 6-amino-penam compounds and pharmaceutical compositions